Mark Eveland
Mass Tort and Class Action Outlook for 2021

Mass Tort and Class Action Outlook for 2021

As we move into 2021, it is helpful to assess the current state of mass torts and class action and think about how these matters may develop over the course of the year. Despite the impact of the COVID pandemic, some matters are picking up momentum, some long-standing...

Mass Tort and Class Action Outlook for 2020

Mass Tort and Class Action Outlook for 2020

The field of mass torts continues to evolve and 2020 will be no exception. One trend we are seeing in mass torts concerns the extension of the statute of limitations, noted in several areas below, in our 2020 mass tort outlook. 3M Combat Arms Earplugs In late August...

Can Common Benefit Fee Disputes be Avoided?

Can Common Benefit Fee Disputes be Avoided?

Recent headlines involving disputes over distribution of the common benefit fund in the pelvic mesh MDL highlight a recurring issue in mass tort litigation. Too often fights erupt when it comes time to distribute common benefit fees, and these fights spill out into...

Data Analysis Vital for Purdue Pharma Opioid Lawsuits

Data Analysis Vital for Purdue Pharma Opioid Lawsuits

The Sackler family is now sending signals that they are interested in a global settlement of the more than 2,000 opioid lawsuits pending against Purdue Pharma as a way to “to get the monies to the communities that need them”. The states and municipalities who brought...